Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Neoantigen-Reactive T Cells: The Driving Force behind Successful Melanoma Immunotherapy.

Davis L, Tarduno A, Lu YC. Neoantigen-Reactive T Cells: The Driving Force behind Successful Melanoma Immunotherapy. Cancers (Basel). 2021 Dec 01; 13(23).

View in: PubMed

collapse authors with profiles